Imugene Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Leslie Chong





Ms. Leslie Chong serves as Non-Executive Director of Chimeric Therapeutics Limited since August 28, 2020. Ms. Chong has been the Chief Executive Officer of Imugene Limited since November 21, 2016. Ms. Chon...

CEO Compensation Analysis

How has Leslie Chong's remuneration changed compared to Imugene's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022AU$1mAU$600k


Mar 31 2022n/an/a


Dec 31 2021n/an/a


Sep 30 2021n/an/a


Jun 30 2021AU$789kAU$408k


Mar 31 2021n/an/a


Dec 31 2020n/an/a


Sep 30 2020n/an/a


Jun 30 2020AU$733kAU$375k


Mar 31 2020n/an/a


Dec 31 2019n/an/a


Sep 30 2019n/an/a


Jun 30 2019AU$777kAU$350k


Mar 31 2019n/an/a


Dec 31 2018n/an/a


Sep 30 2018n/an/a


Jun 30 2018AU$403kAU$300k


Mar 31 2018n/an/a


Dec 31 2017n/an/a


Sep 30 2017n/an/a


Jun 30 2017AU$337kAU$290k


Mar 31 2017n/an/a


Dec 31 2016n/an/a


Sep 30 2016n/an/a


Jun 30 2016AU$323kAU$229k


Compensation vs Market: Leslie's total compensation ($USD819.94K) is about average for companies of similar size in the Australian market ($USD1.06M).

Compensation vs Earnings: Leslie's compensation has increased whilst the company is unprofitable.

Leadership Team

Paul Hopper
Executive Chairman10.25yrsAU$350.00k4.94%
A$ 46.0m
Leslie Chong
CEO, MD & Executive Director6.17yrsAU$1.15m1.2%
A$ 11.2m
Nicholas Ede
Chief Technology Officerno dataAU$490.82k0.29%
A$ 2.7m
Monil Shah
Chief Business Officer1.58yrsAU$1.62mno data
Michael Tonroe
Chief Financial Officer0.33yrno datano data
Ursula McCurry
Senior Vice President of Clinical Operations1yrno datano data
Giovanni Selvaggi
Chief Medical Officer0.25yrno datano data
Nathan Jong
Joint Company Secretary1.08yrsno datano data


Average Tenure

Experienced Management: IMU's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

Paul Hopper
Executive Chairman10.25yrsAU$350.00k4.94%
A$ 46.0m
Leslie Chong
CEO, MD & Executive Director4.83yrsAU$1.15m1.2%
A$ 11.2m
Charles Walker
Independent Non-Executive Director7.33yrsAU$83.41k0.35%
A$ 3.3m
Jens Eckstein
Independent Non-Executive Director3.67yrsAU$85.64k0.32%
A$ 3.0m
Yuman Fong
Chair of Oncolytic Virotherapy Scientific Advisory Board3.17yrsno data0%
A$ 0
Ursula Wiedermann
Member of Scientific Advisory Boardno datano datano data
Neil Segal
Member of Scientific Advisory Board8.75yrsno datano data
Josep Tabernero
Member of Scientific Advisory Board4.25yrsno datano data
Yelena Janjigian
Scientific Advisory Board Member6.75yrsno datano data
Peter Schmid
Member of Scientific Advisory Board5.08yrsno datano data
Tanios Bekaii-Saab
Member of Scientific Advisory Board4.33yrsno datano data
Pravin T. Kaumaya
Member of Scientific Advisory Board4.25yrsno datano data


Average Tenure

Experienced Board: IMU's board of directors are considered experienced (4.8 years average tenure).